KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EPS (Basic) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 169.38%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -52.52%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -45.83%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -185.57%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 4.66%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 53.77%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -7.69%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 8.26%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -52.52%
Dec 28, 2025 49.30%
Sep 28, 2025 91.07%
Jun 29, 2025 17.95%
Mar 30, 2025 238.52%
Dec 29, 2024 -15.48%
Sep 29, 2024 -89.15%
Jun 30, 2024 -1.52%
Mar 31, 2024 4,600.00%
Dec 31, 2023 24.44%
Oct 1, 2023 507.06%
Jul 2, 2023 8.20%
Apr 2, 2023 -101.72%
Oct 2, 2022 22.30%
Jul 3, 2022 -23.11%
Apr 3, 2022 -25.96%
Oct 3, 2021 2.96%
Jul 4, 2021 72.46%
Apr 4, 2021 6.82%
Jan 3, 2021 -56.58%
Sep 27, 2020 101.49%
Jun 28, 2020 -34.60%
Mar 29, 2020 56.03%
Dec 29, 2019 33.33%
Sep 29, 2019 -54.42%
Jun 30, 2019 43.54%
Mar 31, 2019 -13.50%
Dec 30, 2018 128.57%
Sep 30, 2018 5.00%
Jul 1, 2018 3.52%
Apr 1, 2018 0.00%
Dec 31, 2017 -382.98%
Oct 1, 2017 -10.26%
Jul 2, 2017 -2.74%
Apr 2, 2017 0.62%
Jan 1, 2017 21.55%
Oct 2, 2016 28.93%
Jul 3, 2016 -10.43%
Apr 3, 2016 4.52%
Jan 3, 2016 28.89%
Sep 27, 2015 -28.40%
Jun 28, 2015 6.54%
Mar 29, 2015 -7.19%
Dec 28, 2014 -28.00%
Sep 28, 2014 59.43%
Jun 29, 2014 12.50%
Mar 30, 2014 33.60%
Dec 29, 2013 34.41%
Sep 29, 2013 -1.85%
Jun 30, 2013 166.67%
Mar 31, 2013 -12.59%
Dec 30, 2012 1,062.50%
Sep 30, 2012 -7.69%
Jul 1, 2012 -49.50%
Apr 1, 2012 12.60%
Jan 1, 2012 -88.73%
Oct 2, 2011 -5.65%
Jul 3, 2011 -19.20%
Apr 3, 2011 -22.56%
Jan 2, 2011 -11.25%
Oct 3, 2010 2.48%
Jul 4, 2010 7.76%
Apr 4, 2010 29.13%